Bio­Duro-Sun­dia plants its flag at for­mer Par man­u­fac­tur­ing site in CA

A for­mer Par Phar­ma site in Irvine, CA, will now have a new ten­ant.

Bio­Duro-Sun­dia will ac­quire a 40,000-square-foot oral sol­id dose man­u­fac­tur­ing site in Irvine, the com­pa­ny an­nounced Mon­day.

The site will al­low the com­pa­ny to scale up and cater to com­pa­nies that need larg­er-scale pro­duc­tion, Kent Payne, the pres­i­dent of de­vel­op­ment and man­u­fac­tur­ing, said in a press re­lease. The new site should be op­er­a­tional by the start of 2022. It will be able to pro­duce 1 bil­lion tablets and cap­sules a year, the com­pa­ny said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER